Thomas W. Beetham, COO of Viridian Therapeutics, Inc.\DE VRDN, has filed 1 purchase and 0 sales on the open market. The latest trade was on 03/03.

TB

TB

Thomas W. Beetham

COO

Company

Viridian Therapeutics, Inc.\DE VRDN

First filing

23/11/01

Trades

10 trades

Buys / sales

1 / 0

12-month net buying

No record

Last trade

03/03

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Viridian Therapeutics, Inc.\DEVRDN	Open-market buy	24/09/27	24/09/30	5,000 sh	$23.41	$117,050	+500.0%